Identifai Genetics Limited (ASX:ID1)

Australia · Delayed Price · Currency is AUD

0.4800

-0.0050 (-1.03%)

Oct 23, 2026, 4:11 PM AEDT

Identifai Genetics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Profit	-	-	-0.02	-
Operating Income	-2.29	-2.29	-1.58	-1.08
Net Income	-1.72	-1.72	-1.56	-1.06
Earnings Per Share	-1.41	-1.41	-1.28	-0.88
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	0.67	0.67	0.7	1.86
Total Debt	0.03	0.03	0.02	0.02
Net Cash (Debt)	0.64	0.64	0.68	1.84
Net Cash Growth	-	-5.40%	-63.17%	-
Net Cash Per Share	0.52	0.52	0.56	1.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-2.21	-2.21	-	-
Capital Expenditures	-0.02	-0.02	-	-
Free Cash Flow	-2.23	-2.23	-	-
Free Cash Flow Growth	-	-	-	-